🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›AstraZeneca AB
Medicines register · Ireland

AstraZeneca AB — licensed medicines

70 medicines held by AstraZeneca AB on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
70 of 10,336 medicines
Download
Medicine
Active substance
Licence holder
Status
Bevespi Aerosphere 7.2 micrograms/5 micrograms pressurised inhalation, suspension EU/1/18/1339/001
Formoterol fumarate dihydrate, GLYCOPYRRONIUM
AstraZeneca AB
—
Bricanyl 500 micrograms/ml solution for injection or infusion PA1019/007/001
Terbutaline sulfate
AstraZeneca AB
Not marketed
Bricanyl Turbohaler 500 micrograms per metered dose, inhalation powder PA1019/007/002
Terbutaline sulfate
AstraZeneca AB
Marketed
Brilique 60 mg film-coated tablets EU/1/10/655/007-011
Ticagrelor
AstraZeneca AB
—
Brilique 90 mg film-coated tablets EU/1/10/655/001-006
Ticagrelor
AstraZeneca AB
—
Brilique 90 mg orodispersible tablets EU/1/10/655/012-014
Ticagrelor
AstraZeneca AB
—
Bydureon 2 mg powder and solvent for prolonged-release suspension for injection EU/1/11/696/001-004
Exenatide
AstraZeneca AB
—
Bydureon 2 mg prolonged-release suspension for injection in pre-filled pen EU/1/11/696/005-006
Exenatide
AstraZeneca AB
—
BYETTA 10 micrograms Solution for injection EU/1/06/362/3-4
Exenatide
AstraZeneca AB
—
BYETTA 5 micrograms Solution for injection EU/1/06/362/1-2
Exenatide
AstraZeneca AB
—
Calquence 100 mg hard capsules EU/1/20/1479/001-002
Acalabrutinib
AstraZeneca AB
—
Calquence film-coated tablets EU/1/20/1479/001-004
Acalabrutinib maleate
AstraZeneca AB
—
Daxas 250 micrograms tablets EU/1/10/636/008
Roflumilast
AstraZeneca AB
—
Daxas 500 micrograms film-coated tablets EU/1/10/636/001-007
Roflumilast
AstraZeneca AB
—
Ebymect 5 mg/1,000 mg film-coated tablets EU/1/15/1051/007-012
Metformin Hydrochloride, Dapagliflozin propanediol monohydrate
AstraZeneca AB
—
Ebymect 5 mg/850 mg film-coated tablets EU/1/15/1051/001-006
Metformin Hydrochloride, Dapagliflozin propanediol monohydrate
AstraZeneca AB
—
Edistride 10 mg film-coated tablets EU/1/15/1052/006-010
Dapagliflozin propanediol monohydrate
AstraZeneca AB
—
Edistride 5 mg film-coated tablets EU/1/15/1052/001-005
Dapagliflozin propanediol monohydrate
AstraZeneca AB
—
EVUSHELD 150 mg + 150 mg solution for injection EU/1/22/1651/001
Tixagevimab, Cilgavimab
AstraZeneca AB
—
Fasenra 30 mg solution for injection EU/1/17/1252/001-002
Benralizumab
AstraZeneca AB
—
Faslodex 250 mg Solution for injection EU/1/03/269/001-002
Fulvestrant
AstraZeneca AB
—
Fluenz nasal spray suspension Influenza vaccine (live, nasal) EU/1/24/1816/001-002
REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) B/<OFFICIAL STRAIN> LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML, REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/<OFFICIAL STRAIN> (H3N2) LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML, REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/<OFFICIAL STRAIN> (H1N1) LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML
AstraZeneca AB
—
Forxiga 10 mg film-coated tablets EU/1/12/795/006-010
Dapagliflozin propanediol monohydrate equivalent to 10mg dapagliflozin
AstraZeneca AB
—
Forxiga 5 mg film-coated tablets EU/1/12/795/001-005
Dapagliflozin propanediol monohydrate equivalent to 5mg dapagliflozin
AstraZeneca AB
—
IMFINZI 50 mg/ml concentrate for solution for infusion. EU/1/18/1322/001-002
Durvalumab
AstraZeneca AB
—
IMJUDO 20 mg/ml concentrate for solution for infusion EU/1/22/1713/001-002
Tremelimumab
AstraZeneca AB
—
Iressa 250 mg film-coated tablets EU/1/09/526/001-002
Gefitinib
AstraZeneca AB
—
KAVIGALE 300 mg solution for injection/infusion EU/1/24/1900/001
Sipavibart
AstraZeneca AB
—
Komboglyze 2.5 mg/1000 mg film-coated tablets EU/1/11/731/007-012
Metformin Hydrochloride, Saxagliptin
AstraZeneca AB
—
Komboglyze 2.5 mg/850 mg film-coated tablets EU/1/11/731/001-006
Saxagliptin, Metformin Hydrochloride
AstraZeneca AB
—
Koselugo 10 mg hard capsules EU/1/21/1552/001
Selumetinib Sulfate
AstraZeneca AB
—
Koselugo 25 mg hard capsules EU/1/21/1552/002
Selumetinib Sulfate
AstraZeneca AB
—
Koselugo 5 mg granules in capsule for opening EU/1/21/1552/003
Selumetinib Sulfate
AstraZeneca AB
—
Koselugo 7.5 mg granules in capsule for opening EU/1/21/1552/004
Selumetinib Sulfate
AstraZeneca AB
—
Lokelma 10 g powder for oral suspension EU/1/17/1173/003-004
Sodium zirconium cyclosilicate
AstraZeneca AB
—
Lokelma 5 g powder for oral suspension EU/1/17/1173/001-002
Sodium zirconium cyclosilicate
AstraZeneca AB
—
Lynparza 100 mg Film-coated tablet EU/1/14/959/002-003
Olaparib
AstraZeneca AB
—
Lynparza 150 mg Film-coated tablet EU/1/14/959/004-005
Olaparib
AstraZeneca AB
—
Ondexxya Powder for solution for infusion EU/1/18/1345/001
Andexanet alfa
AstraZeneca AB
—
Onglyza 2.5 mg film-coated tablets EU/1/09/545/011-015
Saxaglitpin
AstraZeneca AB
—
Onglyza 5 mg film-coated tablets EU/1/09/545/1-10
Saxagliptin
AstraZeneca AB
—
Oxis Turbohaler 12, inhalation powder PA1019/015/002
Formoterol fumatrate dihydrate
AstraZeneca AB
Not marketed
Oxis Turbohaler 6, inhalation powder PA1019/015/001
Formoterol fumatrate dihydrate
AstraZeneca AB
Not marketed
Pandemic influenza vaccine H5N1 AstraZeneca nasal spray, suspension. Pandemic influenza vaccine (H5N1) (live attenuated, nasal). EU/1/16/1089/001
Strain. a/vietnam/1203/2004 (h5n1) strain (live attenuated)
AstraZeneca AB
—
Pulmicort Respules 0.5 mg/2 ml Nebuliser Suspension PA1019/017/001
Budesonide
AstraZeneca AB
Marketed
Pulmicort Respules 1 mg /2 ml Nebuliser Suspension PA1019/017/002
Budesonide
AstraZeneca AB
Marketed
Pulmicort Turbohaler 100 micrograms Inhalation Powder PA1019/017/003
Budesonide
AstraZeneca AB
Not marketed
Pulmicort Turbohaler 200 micrograms Inhalation Powder PA1019/017/004
Budesonide
AstraZeneca AB
Marketed
Pulmicort Turbohaler 400 micrograms Inhalation Powder PA1019/017/005
Budesonide
AstraZeneca AB
Not marketed
Qtern 5 mg/10 mg film-coated tablets EU/1/16/1108/001-004
Dapagliflozin, Saxagliptin
AstraZeneca AB
—
Showing 1–50 of 70
1 2 Next
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 23 September 2026. https://priyalifescience.com/medicines/company/astrazeneca-ab

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.